Copyright
©The Author(s) 2022.
World J Gastroenterol. Dec 21, 2022; 28(47): 6752-6768
Published online Dec 21, 2022. doi: 10.3748/wjg.v28.i47.6752
Published online Dec 21, 2022. doi: 10.3748/wjg.v28.i47.6752
Figure 8 Interleukin-34 expression was elevated in inflamed mucosa and associated with colonic epithelium proliferation in active ulcerative colitis.
A: Representative microscopic pictures of interleukin-34 (IL-34) immunohistochemical staining in colonic biopsies of healthy controls or individuals with active ulcerative colitis (UC); B: Percentage of IL-34-positive cells per high-power field were quantified in colonic biopsies of healthy controls (n = 20) and active UC patients (n = 40); C: Representative photomicrographs of immunostaining of Ki67 in colonic biopsies of active UC patients in IL-34 Lower expression and higher expression groups; D: Correlation analysis of colonic IL-34 expression and Ki 67-positive cells in active UC patients. IL-34: Interleukin-34; UC: Ulcerative colitis. Scale bar indicates 100 μm or 200 μm. dP < 0.001.
- Citation: Liu ZX, Chen WJ, Wang Y, Chen BQ, Liu YC, Cheng TC, Luo LL, Chen L, Ju LL, Liu Y, Li M, Feng N, Shao JG, Bian ZL. Interleukin-34 deficiency aggravates development of colitis and colitis-associated cancer in mice. World J Gastroenterol 2022; 28(47): 6752-6768
- URL: https://www.wjgnet.com/1007-9327/full/v28/i47/6752.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i47.6752